Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial

por Ferenci, Peter, Caruntu, Florin A., Lengyel, Gabriella, Messinger, Diethelm, Bakalos, Georgios, Flisiak, Robert
Publicado 2016

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

por Ahn, Sang Hoon, Marcellin, Patrick, Ma, Xiaoli, Caruntu, Florin A., Tak, Won Young, Elkhashab, Magdy, Chuang, Wan-Long, Tabak, Fehmi, Mehta, Rajiv, Petersen, Jörg, Guyer, William, Jump, Belinda, Chan, Alain, Subramanian, Mani, Crans, Gerald, Fung, Scott, Buti, Maria, Gaeta, Giovanni B., Hui, Aric J., Papatheodoridis, George, Flisiak, Robert, Chan, Henry L. Y.
Publicado 2018